Not all leaders are good leaders.Perhaps you’ve lost an important executive or you’re establishing a local leadership team. You know that the leader you choose will have a major impact on the organization. So how can you avoid hiring the…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS AZ to Bolster Its Top Position in Breast Cancer Area
November 29, 2011
-
REGULATORY Record 101 Generics from 30 Companies Listed for Aricept
November 29, 2011
-
REGULATORY MHLW Says Sept Drug Price Settlement Rate Dips to 78.1%, Falling Below 2009 Level
November 28, 2011
-
REGULATORY CSIMC to Discuss Additional Price Cuts for Long-Listed Drugs
November 28, 2011
-
ORGANIZATION Economic Losses Due to Illness, Injury Total ¥3.3 Tril. Annually in Japan: ACCJ
November 28, 2011
-
REGULATORY DPJ's Subcommittee for PAL Amendment Begins Deliberations Nov. 28, to Compile Opinion by End-Jan
November 25, 2011
-
ORGANIZATION MSF Japan General Director Expresses Concern Over TPP Negotiations, Possible Generics Price Rise
November 25, 2011
-
REGULATORY Policy Screening Committee Proposes Major Cutbacks in Long-Listed Drug Prices, Additional Decreases Possible
November 24, 2011
-
BUSINESS 25 Leading Drug Makers Report Overall Decline in Sales, Profits in 1st Half
November 24, 2011
-
ACADEMIA JSMO Issues 33 Development Requests for Unapproved Drugs, Indications
November 22, 2011
-
BUSINESS Sanofi, Nichi-Iko to Copromote Latter's Generic Drugs
November 22, 2011
-
BUSINESS Sawai, Nichi-Iko Boost Inventory Ahead of Expected PAL Amendment
November 21, 2011
-
REGULATORY MHLW Study Group Postpones Decision on Relief System for Victims of Health Damages Due to Anticancer Drugs
November 21, 2011
-
REGULATORY After Delay, CSIMC Recommends Listing of Ilaris for Treatment of CAPS
November 21, 2011
-
ORGANIZATION 6 Indian Generics Companies Including Zydus Form Association, to Start Operations This Month
November 18, 2011
-
BUSINESS Teva to Merge Taiyo, Kowa-Teva, Establish “Teva Pharma Japan” in Mid-2012
November 18, 2011
-
BUSINESS Fujifilm, Kyowa Kirin to Set Up Joint Venture for Biosimilars in 2012
November 17, 2011
-
REGULATORY CSIMC Recommends Listing of 9 Products Including Imusera; Recommendation Put on Hold for Ilaris
November 17, 2011
-
REGULATORY High Court Turns Down Iressa Compensation Appeal
November 16, 2011
-
REGULATORY 7-Drug Rule Should Be Relaxed or Eliminated to Promote GE Name Prescribing: Dr Adachi of CSIMC
November 16, 2011
ページ
Earlier this month, Health Minister Keizo Takemi called on the top executives of 13 major generic makers to restructure the industry with a product consolidation target of “around five companies per API.” While a variety of restructuring options are conceivable,…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…